You realize the closing of the acquisition another 3.4 mil. shares are outstanding bringing the total to just over 12.5 mil. This is no longer an itsy bitsy company with 5 mil. shares. OXBT now has a market cap of close to 80 mil. with more dilution coming. Everybody is aware of that right?
These numbers are correct. According to the 11/8/13 press release, “Following these warrant exercises, 9,112,307 shares of the Company’s common stock were issued and outstanding as of November 7, 2013.” According to the 10/21/13 press release, “In connection with the acquisition, Oxygen Biotherapuetics will issue to Phyxius’ stockholders in a private placement an aggregate of approximately 3.4 million unregistered shares of common stock and securities convertible into common stock.”
You can't even add your own numbers: 5 million plus 3.4 equals 8.4 not 12.... so 56 million market cap for a $600 million market with FDA fast approval ... great buy here
Sentiment: Strong Buy